Laboratory Workup for Unexplained Lower Leg Weakness, Foot Drop, and Neuropathy in Diabetes
Order blood glucose/HbA1c, vitamin B12 with metabolites (methylmalonic acid ± homocysteine), and serum protein immunofixation electrophoresis as your core laboratory panel, as these have the highest diagnostic yield for identifying treatable causes of neuropathy beyond diabetes itself. 1
Essential Laboratory Tests
First-Tier Screening (Highest Yield)
Blood glucose and HbA1c: Essential to assess glycemic control, as optimization can prevent progression of diabetic neuropathy 2, 3, 2, 4. Patients with distal symmetric sensory polyneuropathy have high prevalence of pre-diabetes or diabetes that may not be adequately documented 1.
Vitamin B12 with metabolites: Order serum B12 along with methylmalonic acid (with or without homocysteine), as this combination has among the highest yields for identifying treatable neuropathy causes 1. B12 deficiency is a common reversible cause that must be excluded 3.
Serum protein immunofixation electrophoresis (IFE): More sensitive than standard serum protein electrophoresis for detecting monoclonal gammopathies, which occur in approximately 10% of patients with otherwise unexplained polyneuropathy 1. IFE detects 17% of monoclonal gammopathies missed by standard electrophoresis, particularly small IgM gammopathies 1.
Second-Tier Tests Based on Clinical Context
Thyroid function tests (TSH): Hypothyroidism is a recognized cause of neuropathy that must be excluded in diabetic patients 3.
Renal function (creatinine, eGFR): Renal disease can contribute to neuropathy and is common in diabetic patients with microvascular complications 3.
Complete blood count: To screen for malignancies and infections that may cause neuropathy 3.
Erythrocyte sedimentation rate (ESR) and inflammatory markers: Consider for vasculitis screening, though note that CRP and ESR are not useful for diagnosing Charcot neuro-osteoarthropathy if that is suspected 5.
Additional Tests for Specific Clinical Scenarios
Glucose tolerance test (GTT): When routine blood glucose is not clearly abnormal but clinical suspicion for impaired glucose tolerance remains high, particularly with painful neuropathy 1.
HIV testing: In appropriate clinical contexts, as HIV can cause neuropathy 3.
Hepatitis panel: If liver disease or cryoglobulinemia is suspected 1.
Important Clinical Caveats
Diabetic Neuropathy is a Diagnosis of Exclusion
You must actively exclude other treatable causes of neuropathy even in diabetic patients 2, 4. The differential includes:
- Toxins (alcohol) and neurotoxic medications (chemotherapy) 3
- Vitamin B12 deficiency 3, 1
- Hypothyroidism 3
- Renal disease 3
- Malignancies (multiple myeloma, bronchogenic carcinoma) 3
- Infections (HIV) 3
- Chronic inflammatory demyelinating neuropathy 3
- Inherited neuropathies 3
- Vasculitis 3
Consider Charcot Neuro-Osteoarthropathy
With foot drop and lower leg weakness in a diabetic with neuropathy, always consider active Charcot neuro-osteoarthropathy, especially if there is increased temperature, edema, or redness compared to the contralateral foot 5. However, blood tests (CRP, ESR, white blood count, alkaline phosphatase) are not recommended for diagnosing or excluding Charcot foot 5.
Electrophysiological Testing
Nerve conduction studies are rarely needed except when clinical features are atypical or the diagnosis is unclear 2, 3, 2, 3, 4. The sural/radial amplitude ratio may be the most sensitive early parameter for detecting neuropathy in type 1 diabetes 6.
Genetic Testing Considerations
If family history suggests hereditary neuropathy or the clinical picture is atypical, genetic testing for Charcot-Marie-Tooth disease variants may be appropriate, as these tests have 100% specificity and high sensitivity for established pathogenic mutations 1.